• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tamoxifen and thromboembolism.

作者信息

Hendrick A, Subramanian V P

出版信息

JAMA. 1980 Feb 8;243(6):514-5.

PMID:7351776
Abstract
摘要

相似文献

1
Tamoxifen and thromboembolism.他莫昔芬与血栓栓塞
JAMA. 1980 Feb 8;243(6):514-5.
2
Thromboembolic risk of tamoxifen in patients with stage II breast cancer.他莫昔芬在II期乳腺癌患者中的血栓栓塞风险。
J Clin Oncol. 1989 Oct;7(10):1579-80. doi: 10.1200/JCO.1989.7.10.1579.
3
[How I manage patients developing thromboembolic complications as a result of breast cancer treatment with tamoxifen ].我如何处理接受他莫昔芬治疗的乳腺癌患者出现的血栓栓塞并发症
Rev Med Liege. 2002 Dec;57(12):755-6.
4
Hormonal treatment duration in elderly patients: an open question.老年患者的激素治疗持续时间：一个悬而未决的问题。
J Clin Oncol. 2004 Mar 15;22(6):1164-5; author reply 1165. doi: 10.1200/JCO.2004.99.232.
5
Tamoxifen and the factor V Leiden mutation.他莫昔芬与凝血因子V莱顿突变
J Natl Cancer Inst. 2010 Jul 7;102(13):918-9. doi: 10.1093/jnci/djq225. Epub 2010 Jun 16.
6
Breast cancer and duration of tamoxifen.乳腺癌与他莫昔芬的使用时长
Prescrire Int. 2015 Sep;24(163):220.
7
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.他莫昔芬用于预防乳腺癌：国家外科辅助乳腺和肠道项目P-1研究的现状
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372.
8
Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.服用他莫昔芬预防乳腺癌的女性发生静脉血栓栓塞性疾病的遗传和获得性危险因素。
J Clin Oncol. 2003 Oct 1;21(19):3588-93. doi: 10.1200/JCO.2003.10.111.
9
Chemoprevention of breast cancer: recommendations and rationale.乳腺癌的化学预防：建议与理论依据。
Am J Nurs. 2003 May;103(5):107, 109, 111, 113.
10
Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.在国家外科辅助乳腺和肠道项目乳腺癌预防试验中，凝血因子V莱顿突变和凝血酶原G20210A突变对血栓栓塞风险的影响。
J Natl Cancer Inst. 2006 Jul 5;98(13):904-10. doi: 10.1093/jnci/djj262.

引用本文的文献

1
The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation.他莫昔芬对大鼠肝脏UGT2B 基因表达和酶活性的抑制作用导致雌激素内环境稳态失调。
BMC Pharmacol Toxicol. 2022 May 31;23(1):33. doi: 10.1186/s40360-022-00574-6.
2
Liver Infarction and Venous Thromboembolism after Tamoxifen Use in an ADPKD Patient with Encapsulating Peritoneal Sclerosis: A Case Report.他莫昔芬治疗伴有包裹性腹膜硬化的常染色体显性多囊肾病患者后出现肝梗死和静脉血栓栓塞：一例报告
Electrolyte Blood Press. 2020 Dec;18(2):44-48. doi: 10.5049/EBP.2020.18.2.44. Epub 2020 Dec 28.
3
Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.
他莫昔芬在小鼠内分泌治疗早期可诱导肝毒性并导致肝细胞形态改变。
Biomed Rep. 2016 Jan;4(1):102-106. doi: 10.3892/br.2015.536. Epub 2015 Oct 30.
4
Clinical and biomarker predictors of side effects from tamoxifen.他莫昔芬副作用的临床和生物标志物预测因素。
Breast Cancer Res Treat. 2012 Apr;132(3):1107-18. doi: 10.1007/s10549-011-1893-4. Epub 2011 Dec 30.
5
Antiestrogens--tamoxifen, SERMs and beyond.抗雌激素药物——他莫昔芬、选择性雌激素受体调节剂及其他。
Invest New Drugs. 1999;17(3):285-311. doi: 10.1023/a:1006348907994.
6
Tamoxifen and risk of idiopathic venous thromboembolism.他莫昔芬与特发性静脉血栓栓塞症的风险
Br J Clin Pharmacol. 1998 Jun;45(6):608-12. doi: 10.1046/j.1365-2125.1998.00733.x.
7
Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group.化疗内分泌治疗对晚期乳腺癌患者凝血-纤溶系统的影响。日本晚期乳腺癌研究组和日本临床肿瘤学会。
Jpn J Cancer Res. 1993 Apr;84(4):455-61. doi: 10.1111/j.1349-7006.1993.tb00158.x.
8
A risk-benefit assessment of tamoxifen therapy.他莫昔芬治疗的风险效益评估。
Drug Saf. 1993 May;8(5):381-97. doi: 10.2165/00002018-199308050-00005.
9
Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.第十四届加德姆纪念讲座。他莫昔芬治疗和预防乳腺癌的现状
Br J Pharmacol. 1993 Oct;110(2):507-17. doi: 10.1111/j.1476-5381.1993.tb13840.x.
10
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.制定抗雌激素辅助治疗乳腺癌一般原则的实验室研究：问题与未来临床应用潜力
Breast Cancer Res Treat. 1983;3 Suppl:S73-86. doi: 10.1007/BF01855131.